Scorpius Holdings, Inc. (SCPX)

USD 0.29

(-0.87%)

Total Debt Summary of Scorpius Holdings, Inc.

  • Scorpius Holdings, Inc.'s latest annual total debt in 2023 was 14.04 Million USD , up 49.52% from previous year.
  • Scorpius Holdings, Inc.'s latest quarterly total debt in 2024 Q2 was 15.87 Million USD , up 1.3% from previous quarter.
  • Scorpius Holdings, Inc. reported annual total debt of 9.39 Million USD in 2022, up 387.3% from previous year.
  • Scorpius Holdings, Inc. reported annual total debt of 1.92 Million USD in 2021, up 4.24% from previous year.
  • Scorpius Holdings, Inc. reported quarterly total debt of 15.87 Million USD for 2024 Q2, up 1.3% from previous quarter.
  • Scorpius Holdings, Inc. reported quarterly total debt of 9.09 Million USD for 2023 Q1, down -3.12% from previous quarter.

Annual Total Debt Chart of Scorpius Holdings, Inc. (2023 - 2015)

Historical Annual Total Debt of Scorpius Holdings, Inc. (2023 - 2015)

Year Total Debt Total Debt Growth
2023 14.04 Million USD 49.52%
2022 9.39 Million USD 387.3%
2021 1.92 Million USD 4.24%
2020 1.84 Million USD -4.12%
2019 1.92 Million USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 6.74 Million USD 0.0%

Peer Total Debt Comparison of Scorpius Holdings, Inc.

Name Total Debt Total Debt Difference
AIM ImmunoTech Inc. 495 Thousand USD -2736.776%
Ampio Pharmaceuticals, Inc. 274 Thousand USD -5024.833%
Armata Pharmaceuticals, Inc. 120.37 Million USD 88.334%
Actinium Pharmaceuticals, Inc. 2.11 Million USD -564.555%
Azitra, Inc. 885.94 Thousand USD -1484.976%
Can-Fite BioPharma Ltd. 39.99 Thousand USD -35005.985%
Chromocell Therapeutics Corporation 1.26 Million USD -1006.819%
Calidi Biotherapeutics, Inc. 7.23 Million USD -94.058%
CEL-SCI Corporation 13.57 Million USD -3.465%
iBio, Inc. 4.46 Million USD -214.844%
Lineage Cell Therapeutics, Inc. 2.95 Million USD -375.679%
MAIA Biotechnology, Inc. - USD -Infinity%
Matinas BioPharma Holdings, Inc. 3.55 Million USD -294.883%
Navidea Biopharmaceuticals, Inc. 2.43 Million USD -476.84%
NovaBay Pharmaceuticals, Inc. 2.74 Million USD -412.483%
NanoViricides, Inc. - USD -Infinity%
Oragenics, Inc. 312.7 Thousand USD -4390.537%
BiomX Inc. 15.09 Million USD 6.957%
BiomX Inc. 15.09 Million USD 6.957%
Protalix BioTherapeutics, Inc. 26.28 Million USD 46.57%
Palatin Technologies, Inc. 590.33 Thousand USD -2278.645%